John Hess is Head of North America, Global Rare Diseases. Mr. Hess has more than 25 years of experience holding senior and executive roles spanning sales, market access, government policy, patient services, marketing, and operations while leading rare disease, oncology and cardiometabolic franchises in both start-up and large multinational organizations. Throughout his career, Mr. Hess has led several commercial teams through multiple global mergers and acquisitions.
Before joining Chiesi Global Rare Diseases, Mr. Hess was the Director of Commercial Operations for the Americas at ApoPharma. He worked for Daiichi Sankyo for 19 years, where he served as the National Director of Oncology and the West Area Business Director.